Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 161

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 16E
Chunk 161
---
Item 16e.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers

Not applicable.

Item 16f. Change in
Registrant’s Certifying Accountant

Not applicable.

Item 16g. Corporate
Governance

Under Nasdaq Stock Market
Rule 5615(a)(3), foreign private issuers, such as our company, are permitted to follow certain home country corporate governance practices
instead of certain provisions of the Nasdaq Stock Market Rules. A foreign private issuer that elects to follow a home country practice
instead of any such Nasdaq rules must submit to Nasdaq, in advance, a written statement from an independent counsel in such issuer’s
home country certifying that the issuer’s practices are not prohibited by the home country’s laws. We submitted such a written
statement to Nasdaq. See “ Item 6. Directors, Senior Management and Employees - C. Board Practices - Corporate Governance
Requirements under Nasdaq listing rules” for a summary of such differences.

Item 16h. Mine Safety
Disclosure

Not applicable.

Item 16I. Disclosure Regarding
Foreign Jurisdictions that Prevent Inspections.

Not applicable.

Item 16J. Insider trading
policies

Wehave a Securities Trading
Policythat sets out the policy and procedures governing the purchase, sale and other dispositions of the Company’s securities and
applies to directors, officers, employees, contractors and consultants of the Company and its subsidiaries (“ Radiopharm Personnel”).

Our Securities Trading Policy
aims to (i) restrict Radiopharm Personnel in possession of “inside information” from trading in our securities and (ii) ensure
compliance with all applicable securities laws, and listing standards. We have filed our Securities Trading Policy as Exhibit 11.1 to
this Annual Report on Form 20-F.

Item 16K. Cybersecurity